Unani treatment in Psoriasis.

Efficacy of Tila Bars-e-Aswad and Majoon in plaque psoriasis: An open labelled single arm clinical study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023875

Enrollment

Registered

2020-03-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: NIL: NIL Intervention2: Majoon and Tila Bars-e-Aswad: Majoon administered orally twice a day for 45 days and Tila Bars-e-Aswad will be applied topically twice a day for 45 days in sunli

Eligibility

Inclusion criteria

Inclusion criteria: Clinically stable patients of Plaque psoriasis

Exclusion criteria

Exclusion criteria: Patients below and above the age of 18 and 60 years respectively. Patient suffering from concomitant skin diseases like Dermatophytosis, Eczema, Lichen Simplex & Seborrheic Dermatitis. Patient suffering from severe systemic and metabolic diseases. Diabetic and HIV patient. Pregnant & Lactating Women.

Design outcomes

Primary

Measure	Time frame
Evaluation for prognosis with averaged PASITimepoint: 0th,15th day, 30th day and 45th day	—

Secondary

Measure	Time frame
Dermatological Life Quality Index (DLQI) Change in Photograph of skin lesion. Timepoint: 0th,15th day, 30th day and 45th day	—

Countries

India

Contacts

Public ContactAbdul Mobeen

National Institute of Unani Medicine

dr.mobeen@rediffmail.com8123143721

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026